Full Japanese-equity screener
Full-universe value, return, balance-sheet, capital-allocation, and Kabu-priority views.
Kabu Japan equity research
Sign Up
Japan's orphan equities
62% of Japan's small-caps have no sell-side coverage. The filings are Japanese-only, so foreign capital never reads them — Kabu does, and shows you the source behind every name.
Small, profitable, often trading below the value of their own balance sheet — and overlooked, because the people who could read the filings aren't looking, and the people looking can't read them. Unreadable was never uninvestable. That gap is the opportunity. Read the orphan cohort thesis →
See the work
No public track record yet. So the process, source trail, and sample stack are open.
The live portfolio
Deep dives and rebalances publish on Substack. Full-stack subscribers get the publication plus the research tools underneath it.
What app subscribers get
Kabu pairs valuation metrics with translated filings, decision rules, and evidence downloads.
Full-universe value, return, balance-sheet, capital-allocation, and Kabu-priority views.
Yuho, kessan tanshin, and TDnet evidence tied to document IDs and dates.
Normalized earnings, fair-value ranges, and the facts that would break the thesis.
Current coverage
The public sample is open. Subscribers get the full universe and research stack.
| Surface | Public | Subscriber | Status |
|---|---|---|---|
| Screener | 20-name public sample | Full tracked Japan universe | Live |
| Company pages | Metrics preview | Research stack and decision rules | Live |
| Evidence files | Gated | Subscriber document downloads | Live |
Free launch notes and aged deep dives live on Kabu Research on Substack. Follow the work before spending a dollar.